Results 41 to 50 of about 49,377 (194)

Assessing Public Health Impact of Four Pediatric Pneumococcal Conjugate Vaccination Strategies in the Netherlands

Infectious Diseases and Therapy, 2023
Introduction The 10-valent pneumococcal conjugate vaccine (PCV10, Synflorix) was introduced into the Dutch pediatric national immunization program (NIP) starting in 2011.
Michele Wilson, Cheryl McDade, Anna Trisia Beby-Heijtel, Angela Waterval-Overbeek, Vishalini Sundaram, Johnna Perdrizet   +5 more
doaj   +1 more source

Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccine.

PLoS ONE, 2022
Pneumococcal conjugate vaccines reduce the burden of invasive pneumococcal disease, but the sustained effect of these vaccines can be diminished by an increase in disease caused by non-vaccine serotypes.
Sweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, Rebecca R Young, Mohamed Z Patel, Tiny Mazhani, Sefelani Boiditswe, Tirayaone Leburu, Kwana Lechiile, Tonya Arscott-Mills, Andrew P Steenhoff, Kristen A Feemster, Samir S Shah, Coleen K Cunningham, Stephen I Pelton, Matthew S Kelly   +15 more
doaj   +1 more source

Effectiveness and impact of the 10-valent pneumococcal conjugate vaccine, PHiD-CV: review of clinical trials and post-marketing experience

Expert Review of Vaccines, 2018
Introduction: Pneumococcal diseases (including septicemia, meningitis, pneumonia, and upper respiratory infections) constitute a major public health problem.
Tomas Mrkvan, Stephen I. Pelton, Javier Ruiz-Guiñazú, Arto A. Palmu, Dorota Borys   +4 more
doaj   +1 more source

Acute pneumococcal myelitis in an adult patient

Journal of Global Infectious Diseases, 2014
Pneumococcal meningitis represents the most severe community-acquired bacterial meningitis. The disease is frequently associated with various complications.
Klaudija Višković, Matej Mustapić, Marko Kutleša, Dragan Lepur   +3 more
doaj   +1 more source

The potential role of pneumococcal conjugate vaccine in reducing acute respiratory inflammation in community-acquired pneumococcal pneumonia

Journal of Biomedical Science, 2020
Background Pneumococcal conjugate vaccine (PCV) reduces both invasive pneumococcal disease (IPD) and other pneumococcal infections worldwide. We investigated the impact of stepwise implementation of childhood PCV programs on the prevalence of ...
Ching-Fen Shen, Shih-Min Wang, Hsin Chi, Yi-Chuan Huang, Li-Min Huang, Yhu-Chering Huang, Hsiao-Chuan Lin, Yu-Huai Ho, Chao A. Hsiung, Ching-Chuan Liu, Taiwan Pediatric Infectious Disease Alliance   +10 more
doaj   +1 more source

Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012–2024

Human Vaccines & Immunotherapeutics
This narrative review describes pneumococcal serotype prevalence for invasive disease and carriage and antibiotic resistance among specimens collected from children in countries across South and Southeast Asia from 2012 to 2024.
Tzou-Yien Lin, Cheng-Hsun Chiu, Patrick CY Woo, Abdul Razak Muttalif, Raja Dhar, Leong Choon Kit, Graciela Morales, Egemen Ozbilgili   +7 more
doaj   +1 more source

Minimum incidence of adult invasive pneumococcal disease in Blantyre, Malawi an urban african setting: a hospital based prospective cohort study.

PLoS ONE, 2015
Invasive pneumococcal disease causes substantial morbidity and mortality in Africa. Evaluating population level indirect impact on adult disease of pneumococcal conjugate vaccine (PCV) programmes in infants requires baseline population incidence rates ...
Naor Bar-Zeev, Neema Mtunthama, Stephen B Gordon, Gershom Mwafulirwa, Neil French   +4 more
doaj   +1 more source

Understanding the burden of pneumococcal disease in adults [PDF]

Clinical Microbiology and Infection, 2012
Streptococcus pneumoniae causes different types of acute, invasive and non-invasive clinical infections, being the most frequently detected pathogen responsible for community-acquired pneumonia. Pneumococcal pneumonia is accompanied by bacteraemia in 10-30% of cases.
F. Blasi, M. Mantero, P.A. Santus, P. Tarsia   +3 more
openaire   +3 more sources

Pneumococcal Vaccine Uptake in Adults Before and After Hospitalization for Pneumococcal Infections in Hong Kong, 2015 to 2024

Vaccines
Background/Objectives: Vaccination is a key preventive measure against pneumococcal disease, but uptake rates remain low in high-risk populations. Limited information exists on pneumococcal vaccine uptake in individuals with a history of pneumococcal ...
King-Pui Florence Chan, Ting-Fung Ma, James Chung-Man Ho, Ivan Fan-Ngai Hung, Mary Sau-Man Ip, Pak-Leung Ho   +5 more
doaj   +1 more source

Incidence of pneumococcal disease from 2003 to 2019 in children ≤17 years in England

Pneumonia, 2023
Background Pneumococcal disease is a leading cause of communicable disease morbidity and mortality globally. We aimed to estimate invasive pneumococcal disease (IPD), pneumococcal pneumonia (PP) and all-cause pneumonia (ACP) incidence rates (IRs) in ...
Salini Mohanty, Bélène Podmore, Ana Cuñado Moral, Ian Matthews, Eric Sarpong, Alessandra Lacetera, Nawab Qizilbash   +6 more
doaj   +1 more source